Caribbean Investigation of Cancer Stigma and its effect on Cervical Cancer Screening and HPV Vaccination
加勒比癌症耻辱调查及其对宫颈癌筛查和 HPV 疫苗接种的影响
基本信息
- 批准号:10406126
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2021-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
Title: Caribbean Investigation of Cancer Stigma and its effect on Cervical Cancer Screening and HPV Vaccination
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as "NOT-CA-21-026
Cancer stigma is an understudied barrier to cancer treatment seeking, early diagnosis, screening and other prevention
practices. In particular, cervical cancer (CCA) stigma must be prioritized for research as CCA is among the most deadly
but highly preventable cancers. CCA is the fourth most common cancer in the world despite an accurate screening test
and a preventive HPV vaccine. The Human papilloma Virus (HPV) causes 99% of cervical, as well as much of anal,
penile and oral cancers. The burden of CCA persists, and CCA incidence and mortality are even increasing among Black
women in low resourced countries globally. Specifically, CCA incidence is highest, and is the leading cause of premature
mortality among Caribbean women. Despite heightened risk for HPV-related cancer, and readily available, low cost
screening and HPV vaccination (HPVV), both CCA screening and HPV vaccine uptake in the Caribbean region is
perilously low. Our prior, preliminary research suggest that CCA stigma is associated with inadequate screening,
advanced cancer stage at diagnosis, and low uptake of the HPV vaccine among Caribbean populations, both in the
Caribbean region and United States (US). However, both our preliminary studies as well as the literature on CCA-related
stigma, suffer from a lack of population studies that employs qualitative and quantitative methods to rigorously quantify
stigma, and measure stigma’s impact on CCA screening and HPVV. Therefore in an effort to further understand the
impact of cancer stigma on CCA screening and HPVV for the Caribbean context, we aim to 1) culturally transcreate the
existing validated Cancer Stigma Scale (CASS) for population appropriateness, 2) assess cancer stigma in a non-patient
population of men and women using the culturally transcreated CASS in Jamaica and Grenada, 3) assess the association
of stigma and a) cervical cancer screening among women and b) HPVV knowledge and practice --- for participants with
HPVV eligible adolescents. For this study, social norms theory formed the theory, and we will use a mixed-methods
design, rooted in the community engaged research approach. A community advisory council will be appointed in both
Jamaica and Grenada, to inform the transcreation of CASS and overall cultural responsiveness of the study. The study
will use qualitative methods with stakeholders to transcreate and modify CASS. The study survey with the modified
CASS will be distributed via social media and electronic platforms to a population sample (n=1,240). Participants will
complete the survey using a paper-based format and the Research Electronic Data Capture System (REDCap). Based on
our preliminary findings and the lierature, we hypothesize similar stigma scores in the Caribbean (Grenada and Jamaica),
and that Caribbean stigma scores will be higher compared to other countries, and higher stigma scores will be associated
with less cancer screening and lower knowledge, acceptability, and uptake of the HPV vaccine (for those with age
eligible children). The Caribbean region must be emphasized in global cancer research because of its close proximity to
the US and Caribbean immigrants account for 12% of US Blacks. Therefore, the results will inform interventions to
reduce stigma and increase cancer prevention e.g., CCA screening and HPVV among Caribbean populations both in the
Caribbean region and among US Caribbean immigrants to ultimately reduce Black cancer disparities.
项目摘要/摘要
标题:加勒比海癌污名及其对宫颈癌筛查和HPV疫苗接种的影响
该申请是为了响应特殊利益通知(NOSI)而提交
癌症污名是癌症治疗,早期诊断,筛查和其他预防的障碍
实践。特别是,必须将宫颈癌(CCA)污名作为研究优先级,因为CCA是最致命的
但是高度可预防的癌症。 CCA是世界目的地的第四个最常见的癌症
和预防性HPV疫苗。人类乳头状瘤病毒(HPV)导致99%的宫颈以及肛门的大部分
阴茎和口服癌。 CCA的Burnen持续存在,CCA的发病率和死亡率甚至在黑色中增加
全球低资源国家的妇女。具体而言,CCA事件最高,是过早的主要原因
加勒比妇女的死亡率。尽管患有HPV相关癌症的风险较高,并且容易获得,但成本较低
筛查和HPV疫苗(HPVV),CCA筛查和加勒比地区的HPV疫苗摄取均为
危险低。我们先前的初步研究表明,CCA污名与筛查不足有关,
诊断时的晚期癌症阶段,加勒比海人群中HPV疫苗的摄取量低
加勒比地区和美国(美国)。但是,我们的初步研究以及有关CCA相关的文献
污名,缺乏人口研究,该研究采用定性和定量方法来严格量化
污名,并衡量污名对CCA筛查和HPVV的影响。因此,为了进一步了解
癌症污名对加勒比海环境中CCA筛查和HPVV的影响,我们的目标是1)文化创造
现有的经过验证的癌症污名量表(CASS)用于人口适当性,2)评估非患者的癌症污名
使用牙买加和格林纳达的文化转录Cass的男性和女性人口,3)评估该关联
妇女和a)女性宫颈癌筛查的污名和b)HPVV知识和实践 -
HPVV合格的青少年。在这项研究中,社会规范理论形成了理论,我们将使用混合方法
设计,植根于社区参与研究方法。两者都将任命社区咨询委员会
牙买加和格林纳达,以告知CASS的转录和研究的整体文化反应能力。研究
将使用利益相关者使用定性方法来转造和修改CASS。修改后的研究调查
CASS将通过社交媒体和电子平台分发给人群样本(n = 1,240)。参与者会
使用基于纸张的格式和研究电子数据捕获系统(REDCAP)完成调查。基于
我们的初步发现和谎言,我们假设在加勒比海(格林纳达和牙买加)中的类似污名得分,
与其他国家相比
癌症筛查较少,知识较低,可接受性和HPV疫苗的吸收(对于患有年龄的人
合格的孩子)。加勒比地区必须在全球癌症研究中强调,因为它与
美国和加勒比移民占美国黑人的12%。因此,结果将为干预提供信息
降低污名并增加预防癌症,例如,加勒比海人群中的CCA筛查和HPVV都在
加勒比地区以及美国加勒比海移民最终减少黑人癌症分布。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
STEVEN Terry ROSEN的其他基金
Novel targeted therapies for HPV-associated Non-AIDS-defining cancers (Biospecimens/Biocohort)
针对 HPV 相关非艾滋病定义癌症的新型靶向疗法(生物样本/生物队列)
- 批准号:1062008310620083
- 财政年份:2022
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Genomic and Microenvironment Analysis of HIV-Associated Diffuse Large B-cell Lymphoma (Immuno/Microenvironment)
HIV 相关弥漫性大 B 细胞淋巴瘤的基因组和微环境分析(免疫/微环境)
- 批准号:1062007410620074
- 财政年份:2022
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Creating an Efficient Clinical Trial Build System Via the Clinical Trials Rapid Activation Consortium (CTRAC)
通过临床试验快速激活联盟 (CTRAC) 创建高效的临床试验构建系统
- 批准号:1022758910227589
- 财政年份:2020
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:1052522910525229
- 财政年份:2018
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:1005737110057371
- 财政年份:2018
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
靶向 p38 γ 信号传导以推进皮肤 T 细胞淋巴瘤治疗
- 批准号:1029666710296667
- 财政年份:2018
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:92432269243226
- 财政年份:2016
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:91072129107212
- 财政年份:2016
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:99007489900748
- 财政年份:2016
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia
治疗急性髓系白血病的新型 RNA 导向疗法
- 批准号:94587079458707
- 财政年份:2016
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:1089652510896525
- 财政年份:2023
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:1089652310896523
- 财政年份:2023
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:1068654210686542
- 财政年份:2023
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Using Re-inforcement Learning to Automatically Adapt a Remote Therapy Intervention (RTI) for Reducing Adolescent Violence Involvement
使用强化学习自动调整远程治疗干预 (RTI),以减少青少年暴力参与
- 批准号:1083433910834339
- 财政年份:2023
- 资助金额:$ 21.96万$ 21.96万
- 项目类别:
Examining Prenatal Inflammation and Neurodevelopment in a Longitudinal Fetal-to-Age 9 Imaging Study - Administrative Supplement
在胎儿至 9 岁纵向影像学研究中检查产前炎症和神经发育 - 行政补充
- 批准号:1081877610818776
- 财政年份:2023
- 资助金额:$ 21.96万$ 21.96万
- 项目类别: